Biostar Pharmaceuticals Inc (BSPM)

Trade-Ideas LLC identified Biostar Pharmaceuticals (BSPM) as a weak on high relative volume candidate

Trade-Ideas LLC identified Biostar Pharmaceuticals (BSPM) as a strong on high relative volume candidate

Trade-Ideas LLC identified Biostar Pharmaceuticals (BSPM) as a weak on high relative volume candidate

Here's a technical look at how to trade several under-$10 stocks that are poised for breakouts.

Trade-Ideas LLC identified Biostar Pharmaceuticals (BSPM) as a strong on high relative volume candidate

Trade-Ideas LLC identified Biostar Pharmaceuticals (BSPM) as a weak on high relative volume candidate

Trade-Ideas LLC identified Biostar Pharmaceuticals (BSPM) as a "perilous reversal" (up big yesterday but down big today) candidate

Trade-Ideas LLC identified Biostar Pharmaceuticals (BSPM) as a strong on high relative volume candidate

These under -$10 stocks are poised to breakout and trade higher from current levels.

Trade-Ideas LLC identified Biostar Pharmaceuticals (BSPM) as a weak on high relative volume candidate

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ACLS, AGU, BRKR, CVU, EMC, GIGM, GSOL, SPAN, VIAB, XOXO Downgrades: BBW, BSPM, CJES, CRZO, EGN, ENTA, GCAP, GLP, HL, NGS, NWPX, SNP, TESO, WCC Initiations: NSAM Read on to get TheStreet Quant Ratings' detailed report:

Looking for setups that often produce monster moves higher in very short time frames.

Upgrades: BPHX, BSPM, BSQR, CGI, COBK, COHR, CUO, DRAD, DTSI, EDUC, IFON, MBTF, MFRM, MPAA, MTZ, NSU, OBCI, PVA, SCX, SNFCA, THTI, TREX, WVVI Downgrades: CFFI, JMP, JOY, LYV, NEWS, NOR, OKSB, PRGS, RTK, SGMA, SLAB, SPOK, VALU, WBKC Initiations: ANIP Read on to get TheStreet Quant Ratings' detailed report:

Pharmaceutical companies are profiting from China’s urban ailments and a growing appetite for western-style medicinal treatments

Upgrades: ABR, ALN, ASBI, BRLI, HK, NSEC, PCL, QLYS, SMTP Downgrades: AIRI, BSPM, BVX, CNTY, EC, MCEP, OIS, VCO, VRA Initiations: RALY Read on to get TheStreet Quant Ratings' detailed report:

These stocks look ready to break out and trade higher from current levels.

Biostar Pharmaceuticals (Nasdaq:BSPM) has been upgraded by TheStreet Ratings from a sell to hold.

Upgrades: BSPM, NOAH, NTS, TAIT, XOMA Downgrades: AYR, CFFN, HST, ISSC, NFEC, PWRD Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.

Shares of Biostar Pharmaceuticals (Nasdaq:BSPM) have taken a tremendous swing upward. The stock is trading at $1.78 as of 10:33 a.m. ET, 21.1% above Wednesday's closing price of $1.47. Volume is at 669,682, 11.7 times the daily average of 57,200.

Shares of Biostar Pharmaceuticals (Nasdaq:BSPM) have taken a tremendous swing upward. The stock is trading at $1.29 as of 9:54 a.m. ET, 20.6% above Tuesday's closing price of $1.07. Volume is at 51,086, 0.9 times the daily average of 57,900.

Shares of Biostar Pharmaceuticals (Nasdaq:BSPM) have taken a tremendous swing upward. The stock is trading at $2.05 as of 10:05 a.m. ET, 24.2% above Friday's closing price of $1.65. Volume is at 135,147, 1.9 times the daily average of 72,400.

Shares of Biostar Pharmaceuticals (Nasdaq:BSPM) have taken a tremendous swing upward. The stock is trading at $1 as of 9:39 a.m. ET, 27% above Thursday's closing price of 79 cents. Volume is at 875,524, 12.6 times the daily average of 69,400.

Shares of Biostar Pharmaceuticals (Nasdaq:BSPM) have taken a tremendous swing upward. The stock is trading at 59 cents as of 12:09 p.m. ET, 20.4% above Monday's closing price of 49 cents. Volume is at 107,478, 1.5 times the daily average of 70,800.

Biostar Pharmaceuticals (Nasdaq:BSPM) has been upgraded by TheStreet Ratings from a sell to hold.

Biostar Pharmaceuticals (Nasdaq:BSPM) has been downgraded by TheStreet Ratings from from a hold to sell.

Shares of Biostar Pharmaceuticals (Nasdaq:BSPM) have taken a tremendous swing upward. The stock is trading at $2.97 as of 10:07 a.m. ET, 33.8% above Thursday's closing price of $2.22. Volume is at 3.9 million, 26.1 times the daily average of 150,700.

Shares of Biostar Pharmaceuticals (Nasdaq:BSPM) have taken a tremendous swing upward. The stock is trading at $2.18 as of 12:21 p.m. ET, 21.1% above Monday's closing price of $1.80. Volume is at 234,068, 1.7 times the daily average of 137,400.